Asensus Surgical, Inc.
ASXC · AMEX
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $80 | $82 | $252 | $45 |
| - Cash | $17 | $6 | $18 | $16 |
| + Debt | $6 | $6 | $6 | $3 |
| Enterprise Value | $68 | $81 | $239 | $31 |
| Revenue | $9 | $7 | $8 | $3 |
| % Growth | 21% | -13.9% | 159.3% | – |
| Gross Profit | -$5 | -$4 | -$3 | -$2 |
| % Margin | -53.4% | -53.4% | -34.8% | -62.7% |
| EBITDA | -$74 | -$64 | -$48 | -$47 |
| % Margin | -867.4% | -907.1% | -580.1% | -1,483.8% |
| Net Income | -$78 | -$76 | -$62 | -$59 |
| % Margin | -914.5% | -1,066.2% | -758.8% | -1,868.1% |
| EPS Diluted | -0.31 | -0.32 | -0.28 | -0.85 |
| % Growth | 3.1% | -14.3% | 67.1% | – |
| Operating Cash Flow | -$64 | -$59 | -$41 | -$47 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$0 |
| Free Cash Flow | -$64 | -$60 | -$42 | -$47 |